Join
Live feed
·
PRReleasevia Quantisnow
Orchard Therapeutics plc logo

Orchard Therapeutics Extends Runway into 2024, Focusing HSC Gene Therapy Platform Exclusively on Severe Neurometabolic Diseases and Research Platform

ByQuantisnow·Wall Street's wire, on your screen.
ORTX· Orchard Therapeutics plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORTX (Orchard Therapeutics plc) and more on Quantisnow.